-
Sat05Sep2026Wed09Sep2026
-
Thu10Sep2026
-
Thu01Oct2026Sat03Oct2026
-
Sat03Oct2026Sun04Oct2026
-
Sun04Oct2026Wed07Oct2026
-
Tue06Oct2026Fri09Oct2026
-
Wed14Oct2026Fri16Oct2026Santiago de Compostela, Spain
-
Tue17Nov2026Sat21Nov2026
Latest News
US FDA approves Abbott’s longer-length Esprit for severe PAD
The US Food and Drug Administration (FDA) has approved Abbott’s new longer-length Esprit BTK system for the treatment of chronic limb-threatening ischaemia (CLTI).
The longer-length...
Features
Rethinking interventions for asymptomatic carotid stenosis
Caitlin Hicks (Baltimore, USA) reflects on CREST-2 following publication of the trial late last year.
After nearly a decade of enrolment and follow-up, CREST-2 provides...
From the operating theatre to Westminster, PAD needs a unifying voice
In the first of a series of regular columns, Rachael Forsythe (Edinburgh, UK) provides an update from the Circulation Foundation—the UK’s only national charity...
Videos
Sanjay Misra (Mayo Clinic, Rochester, USA) comments on the recently presented findings from the primary cohort of the IN.PACT AV Access post-approval study (PAS), evaluating real-world outcomes in patients treated for arteriovenous (AV) fistula stenosis. Speaking to Vascular News,...
